LifeStance Health Group, Inc.
LFST
$5.87
$0.020.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.30% | 4.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.30% | 4.08% | |||
| Cost of Revenue | 3.30% | 1.77% | |||
| Gross Profit | 0.32% | 8.97% | |||
| SG&A Expenses | 1.29% | 9.79% | |||
| Depreciation & Amortization | -6.24% | -2.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.29% | 3.72% | |||
| Operating Income | 4.29% | 279.75% | |||
| Income Before Tax | 83.44% | -64.92% | |||
| Income Tax Expenses | -23.53% | -406.78% | |||
| Earnings from Continuing Operations | 109.97% | -19.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 109.97% | -19.39% | |||
| EBIT | 4.29% | 279.75% | |||
| EBITDA | -5.24% | 4.44% | |||
| EPS Basic | 109.63% | -19.11% | |||
| Normalized Basic EPS | 82.09% | -63.41% | |||
| EPS Diluted | 109.63% | -19.11% | |||
| Normalized Diluted EPS | 82.09% | -63.41% | |||
| Average Basic Shares Outstanding | 0.74% | 0.02% | |||
| Average Diluted Shares Outstanding | 2.69% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||